PeptideDB

Taurodeoxycholic acid sodium hydrate

CAS No.: 110026-03-4

Taurodeoxycholic acid sodium hydrate (Sodium taurodeoxycholate monohydrate), a hydrophilic bile salt, on bile salt and b
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Taurodeoxycholic acid sodium hydrate (Sodium taurodeoxycholate monohydrate), a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat.
In vivo At all infusion rates, taurohyodeoxycholic acid caused a greater (P < 0.001) secretion of biliary lecithin compared to the other bile salts. There were no significant differences in the biliary secretion of cholesterol and proteins. Electron microscopy showed the recruitment of vesicles and lamellar bodies around and within bile canaliculi. In conclusion, taurohyodeoxycholic promotes a biliary lecithin secretion greater than expected from physicochemical predictions, representing a novel secretory property with potential pharmacological relevance[1].
Synonyms Sodium taurodeoxycholate monohydrate, Taurodeoxychloic Acid sodium hydrate, Taurohyodeoxycholic acid sodium salt, 牛磺猪去氧胆酸
molecular weight 540.71
Molecular formula C26H47NNaO7S
CAS 110026-03-4
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 125 mg/mL (231.18 mM)
References 1. Angelico M , Baiocchi L , Nistri A , et al. Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat[J]. Digestive Diseases & Sciences, 1994, 39(11):2389-2397. 2. Roda A , Piazza F , Baraldini M , et al. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid–induced cholestasis in the rat[J]. Hepatology, 1998, 27.